As of Nov 2, 2026: Yann Echelard (Director, TGTX) reported 1 sale for $163K in the last 12 months (Form 4). TGTX's Quality Score is 21. Scores as of 3:51 PM ET, 15 minutes behind.

YE

Yann Echelard

Director of TG Therapeutics

1 stock trade in the last 12 months, shares they bought or sold themselves (not grants or options).

Bought: $0, 12 monthsSold: $163K, 12 monthsLast filed: Nov 25, 2025, a sale

Follow Yann EchelardFollowing Yann EchelardFollow EchelardFollowing EchelardOpen TGTX in the scannerOpen TGTX

From SEC Form 4s · Insiders have 2 business days to file a trade

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See the tradeSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Sign inSigned out. Sign in to keep going.

Create my free accountNo password. Nothing else to fill in.

Create my free accountYour guest pass has ended. No password needed.

Upgrade to ProEvery stock ranked, with prices that refresh every 2.5 seconds during market hours.

Every trade Yann Echelard reported

Newest first, as filed

Stock	Trade	Amount	Trade	Shares	Traded Filed
TGTXTG Therapeutics	Sell	$163Kat $32.57	Sell$163Kat $32.57	5,000 at $32.57	Nov 24, 2025filed Nov 25, 2025SEC filing

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it ›

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See the tradeSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Sign inSigned out. Sign in to keep going.

Create my free accountNo password. Nothing else to fill in.

Create my free accountYour guest pass has ended. No password needed.

Upgrade to ProEvery stock ranked, with prices that refresh every 2.5 seconds during market hours.

Yann Echelard's companies

Where they file, with the stock's Quality Score

Company	Title, as filed	Trades	Quality Score
TGTXTG TherapeuticsDirector	Directorfiled Nov 25, 2025	1	21

Alerts for Yann Echelard

One alert for each Form 4 they file.

Set an alert

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Use this page

Kept by Andrew Gomes, Breakaway's founder, from the SEC's Form 4 filings. Updated Nov 25, 2025.

Free to reuse with a link to this page.

How to cite

Breakaway, Yann Echelard: Director at TG Therapeutics (TGTX), Nov 25, 2025, getbreakaway.com/insiders/yann-echelard

Copy

Journalists: email support@getbreakaway.com for the data behind this page.

Others who file at TG Therapeutics

• Michael S. WeissCEO
• Sean A. PowerCFO
• Laurence N. CharneyDirector

Insider trades by person⁠ ›